Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Friberg

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Heart Rhythm|April 11, 2024
Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablationFinn Åkerström, Emmanouil Charitakis, Astrid Paul-Nordin, et al.
Journal of the American Heart Association|May 16, 2022
Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass GraftingAmar Taha, Susanne J Nielsen, Stefan Franzén, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 15, 2015
Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recordingMattias Aronsson, Emma Svennberg, Mårten Rosenqvist, et al.
Journal of the American Heart Association|March 3, 2017
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal DysfunctionKarolina Szummer, Alessandro Gasparini, Staffan Eliasson, et al.
Circulation|September 1, 2024
Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP IIKatrin Kemp Gudmundsdottir, Emma Svennberg, Leif Friberg, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 3, 2019
Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II studyKatrin Kemp Gudmundsdottir, Tove Fredriksson, Emma Svennberg, et al.
European Heart Journal|November 9, 2022
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP studyJohan Lyth, Emma Svennberg, Lars Bernfort, et al.
Expert Opinion on Drug Safety|July 24, 2020
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practiceLuis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, et al.
BMJ Open|March 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in EuropeGunnar Brobert, Ana Ruigomez, Tania Schink, et al.
Heart (British Cardiac Society)|September 1, 2023
Association between catheter ablation of atrial fibrillation and mortality or strokeFinn Akerström, Julie Hutter, Emmanouil Charitakis, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Heart Rhythm|April 11, 2024
Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablationFinn Åkerström, Emmanouil Charitakis, Astrid Paul-Nordin, et al.
Journal of the American Heart Association|May 16, 2022
Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass GraftingAmar Taha, Susanne J Nielsen, Stefan Franzén, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 15, 2015
Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recordingMattias Aronsson, Emma Svennberg, Mårten Rosenqvist, et al.
Journal of the American Heart Association|March 3, 2017
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal DysfunctionKarolina Szummer, Alessandro Gasparini, Staffan Eliasson, et al.
Circulation|September 1, 2024
Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP IIKatrin Kemp Gudmundsdottir, Emma Svennberg, Leif Friberg, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 3, 2019
Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II studyKatrin Kemp Gudmundsdottir, Tove Fredriksson, Emma Svennberg, et al.
European Heart Journal|November 9, 2022
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP studyJohan Lyth, Emma Svennberg, Lars Bernfort, et al.
Expert Opinion on Drug Safety|July 24, 2020
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practiceLuis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, et al.
BMJ Open|March 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in EuropeGunnar Brobert, Ana Ruigomez, Tania Schink, et al.
Heart (British Cardiac Society)|September 1, 2023
Association between catheter ablation of atrial fibrillation and mortality or strokeFinn Akerström, Julie Hutter, Emmanouil Charitakis, et al.
Pageof 8